Cerebral venous sinus thrombosis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
 
(3 intermediate revisions by the same user not shown)
Line 100: Line 100:
|
|
* [[Headache|Severe headache]] (patients demonstrate as the worst headache in their life)
* [[Headache|Severe headache]] (patients demonstrate as the worst headache in their life)
* Headache is the main symptom (often starts suddenly and starts after a popping or snapping feeling in the head)
* Most common [[symptom]] is [[headache]]
* [[Diplopia]]
* [[Diplopia]]
* [[Nausea]], [[vomiting]]
* [[Nausea]], [[vomiting]]
Line 112: Line 112:
|
|
* [[Lumbar puncture|Lumbar puncture (LP)]] is required in case of a strong suspicion of [[subarachnoid hemorrhage]]. LP will show:
* [[Lumbar puncture|Lumbar puncture (LP)]] is required in case of a strong suspicion of [[subarachnoid hemorrhage]]. LP will show:
** Elevated opening pressure
** Raised opening pressure
** Elevated [[Red blood cell|red blood cell (RBC)]]
** Raised [[Red blood cell|red blood cell (RBC)]]
** [[Xanthochromic|Xanthochromia]]
** [[Xanthochromic|Xanthochromia]]
|-
|-
Line 127: Line 127:
|[[Lumbar puncture]] for [[CSF]]
|[[Lumbar puncture]] for [[CSF]]
|
|
* [[CT]] scan of the head may be performed before [[Lumbar puncture|LP]] to determine the risk of [[herniation]].
* To determine the risk of [[herniation]] [[CT scan]] of the [[head]] should be done before [[Lumbar puncture]].
|
|
* Diagnosis is based on clinical presentation in combination with [[CSF]] analysis.  
* [[Clinical]] presentation in combination with [[CSF]] [[analysis]] are deciding factors for [[diagnosis]].  
* [[CSF]] analysis is the test of choice.
* [[CSF]] analysis is the test of choice.
* For more information on [[CSF]] analysis in meningitis please [[Meningitis#Diagnosis|click here.]]
 
|-
|-
|[[Intracranial mass]]
|[[Intracranial mass]]
Line 144: Line 144:
|[[MRI]]
|[[MRI]]
|
|
* [[CT]] or [[MRI]] is the initial test to detect intracranial lesions.  
* To detect intracranial [[lesions]] [[CT]] or [[MRI]] is the initial test of choice.  
* These imaging tests determine the location of [[intracranial mass]] lesion(s) and help in guiding [[therapy]].
* To determine the location of [[intracranial mass]] lesion(s) and treatment method, imgaing findings are helpful.
|
|
* [[Biopsy]] of the lesion is needed to identify the nature of the lesion such as:
* [[Biopsy]] of the [[lesion]] is needed To identify the natures of the [[lesions]] such as:
** [[Tumor]]  
** [[Tumor]]  
** [[Abscess]]
** [[Abscess]]


* X- ray of the skull is a non specific test, but useful if any of the lesions are [[Calcified lesion|calcified]].
* X- ray of the skull is a non specific test, but useful to identify [[Calcified lesion|calcified]] [[lesions]].
|-
|-
|[[Cerebral hemorrhage]]
|[[Cerebral hemorrhage]]
Line 157: Line 157:
* [[Headache]], vomiting, and depressed level of [[consciousness]] from [[increased intracranial pressure]] (ICP)  
* [[Headache]], vomiting, and depressed level of [[consciousness]] from [[increased intracranial pressure]] (ICP)  


* Progression of focal neurological deficits over periods of hours
* Progressive focal neurological deficits  
|[[CT]] scan without contrast
|[[CT]] scan without contrast
|
|
* [[CT scan]] without contrast is the initial test performed to differentiate [[ischemic stroke]] and rule out [[hemorrhagic stroke|hemorrhagic stroke.]]
* [[CT scan]] without contrast is the initial test to differentiate [[ischemic stroke]] and rule out [[hemorrhagic stroke|hemorrhagic stroke.]]
* [[CT]] is very sensitive for identifying acute [[hemorrhage]] which appears as hyperattenuating clot.
* Acute [[hemorrhage]] appears as a hyperattenuating clot in [[CT scan]].
* Gradient echo and T2 susceptibility-weighted [[MRI]] are as sensitive as [[CT]] for detection of acute hemorrhage and are more sensitive for identification of prior hemorrhage.
* Gradient echo and T2 susceptibility-weighted [[MRI]] are equally sensitive as [[CT]] for detection of acute hemorrhage and are more sensitive to identify prior hemorrhage.
|
|
* [[PT]]/ [[INR]] and [[aPTT]] should be checked to rule out [[coagulopathy]].
* [[Coagulopathy]] should be ruled out by checking [[PT]]/ [[INR]] and [[aPTT]].


|-
|-
|[[Cerebral]] [[Infarction]]
|[[Cerebral]] [[Infarction]]
|The [[symptoms]] of an [[ischemic stroke]] vary widely depending on the site and blood supply of the area involved. For more information on [[symptoms]] of [[ischemic stroke]] based on area involved please [[Ischemic stroke#Diagnosis#History and symptoms|click here]].  
|The [[symptoms]] of an [[ischemic stroke]] depend on the site and [[blood]] supply of the area involved.
|[[Cerebral angiography]]
|[[Cerebral angiography]]
|
|
* [[CT scan]] without contrast is the initial test performed to diagnose [[ischemic stroke]] and rule out [[hemorrhagic stroke|hemorrhagic stroke.]] CT may show hypo-attenuation and swelling of involved area.
* [[CT scan]] without contrast is the initial test to diagnose [[ischemic stroke]] and to exclude [[hemorrhagic stroke|hemorrhagic stroke.]] Hypo-attenuation and swelling of the involved area may be found in the [[CT scan]].
* [[MRI|MR]] diffusion weighted imaging is the most sensitive and specific test for diagnosing [[ischemic stroke]] and may help detect presence of [[infarction]] in few minutes of onset of [[symptoms]].  
* [[MRI|MR]] diffusion-weighted imaging is the most sensitive and specific test to diagnose [[ischemic stroke]] and in few minutes of the onset of [[symptoms]], MRI can detect the [[infarction]].  
|
|
* [[Carotid]] [[doppler]] may be done to check for patency of [[carotid arteries]] and blood supply to the [[brain]].
* [[Carotid]] [[doppler]] may be done to check for patency of [[carotid arteries]] and blood supply to the [[brain]].


* [[Cerebral angiography]] is an [[Invasive (medical)|invasive]] test and detect [[abnormalities]] of the [[blood vessels]], including narrowing, blockage, or [[malformations]] (such as [[Aneurysm|aneurysms]] or [[arterio-venous malformations]]). 
* [[Cerebral angiography]] detect [[blood vessels]] [[abnormalities]] as narrowing, blockage, or [[malformations]] (such as [[Aneurysm|aneurysms]] or [[arterio-venous malformations]]). 
|-
|-
|[[Migraine]]
|[[Migraine]]
|
|
* Severe or moderate [[headache]] (which is often one-sided and pulsating) lasts between several hours to three days.
* Severe or moderate [[headache]] (often unilateral) lasting several hours to three days.
* Other [[symptoms]] include gastrointestinal upsets, such as [[nausea and vomiting]], and a heightened sensitivity to bright lights ([[photophobia]]) and noise ([[phonophobia]]). Approximately one third of people who experience [[migraine]] get a preceding [[Aura (symptom)|aura]].<sup>[[Migraine overview#cite note-4|[4]]]</sup>   
* Other [[symptoms]] include gastrointestinal upsets, such as [[nausea and vomiting]], and an increased sensitivity to bright lights ([[photophobia]]) and sound ([[phonophobia]]). [[Aura (symptom)|aura]] is a preceding symptom in one third patients.<sup>[[Migraine overview#cite note-4|[4]]]</sup>   
|'''---'''
|'''---'''
|
|
* [[CT]] and [[MRI]] may be needed to rule out other suspected possible causes of [[headache]].
* To exclude other suspected possible [[causes]] of [[headache]] [[CT]] and [[MRI]] might be required.


|[[Migraine]] is a clinical [[diagnosis]] that does not require any laboratory tests. Laboratory tests can be ordered to rule out any suspected coexistent metabolic problems or to determine the baseline status of the patient before initiation of [[migraine]] therapy.
|[[Migraine]] does not need any diagnostic test; it is a clinical diagnosis. To rule out any suspected coexistent metabolic problems or to determine the baseline status of the patient before initiation of [[migraine]] [[therapy]] [[laboratory]] tests can be done.
|-
|-
|[[Head injury]]
|[[Head injury]]
Line 200: Line 200:
|[[CT]] scan without contrast
|[[CT]] scan without contrast
|
|
* [[CT]] scan is the first test performed and identifies [[cerebral hemorrhage]] (appears as hyperattenuating clot) following head injury. [[CT]] scan is also less time consuming.
* [[CT]] scan is the first test to identify [[cerebral hemorrhage]] (appears as hyperattenuating clot) after head injury.  


* [[MRI]] is more sensitive, takes more time and is done in patients with symptoms unexplained by [[Computed tomography|CT]] scan.  
* [[MRI]] is time-consuming, expensive, and is done in cases with nonspecific findings in [[CT scans]].  
|
|
* The [[Glasgow Coma Scale]] is a tool for measuring degree of unconsciousness and is thus a useful tool for determining severity of injury.  
* The [[Glasgow Coma Scale]] is used to determine the severity of the injury.  
* The [[Pediatric Glasgow Coma Scale]] is used in young children.
* The [[Pediatric Glasgow Coma Scale]] is used in young children.
|-
|-
|[[Lymphocytic hypophysitis]]
|[[Lymphocytic hypophysitis]]
|[[Lymphocytic hypophysitis]] is most often seen in late pregnancy or the [[postpartum]] period with the following symptoms:
|[[Lymphocytic hypophysitis]] is most common in late pregnancy or the [[postpartum]] period with the following symptoms:
* Mass lesion effect such as [[headache]] or [[Visual field defect|visual field defects]]
* Mass lesion effect such as [[headache]] or [[Visual field defect|visual field defects]]
* [[Hypopituitarism]]
* [[Hypopituitarism]]
|Pituitary biopsy
|Pituitary biopsy
|
|
* [[CT]] & [[MRI]] typically reveal features of a pituitary mass.
* [[CT]] & [[MRI]] are helpful to identify a [[pituitary]] [[mass]].
|
|
* The most accurate test is pituitary [[biopsy]] which will show [[lymphocytic]] [[Infiltration (medical)|infiltration]].
* [[Lymphocytic]] [[Infiltration (medical)|infiltration]] in pituitary biopsy confirms the diagnosis.
|-
|-
|[[Radiation injury]]
|[[Radiation injury]]
Line 229: Line 229:
* Contrast-enhancing mass surrounded by [[edema]] and mass effect
* Contrast-enhancing mass surrounded by [[edema]] and mass effect
|[[PET scan]]
|[[PET scan]]
* [[Radiation]] [[necrosis]] is hypo metabolic and will have decreased uptake of [[fluorodeoxyglucose]].
* [[Radiation]] [[necrosis]] is hypo metabolic and shows reduced uptake of [[fluorodeoxyglucose]].


|}
|}

Latest revision as of 01:19, 3 August 2021

Cerebral venous sinus thrombosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Differentiating Cerebral venous sinus thrombosis from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cerebral venous sinus thrombosis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cerebral venous sinus thrombosis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cerebral venous sinus thrombosis differential diagnosis

CDC on Cerebral venous sinus thrombosis differential diagnosis

Cerebral venous sinus thrombosis differential diagnosis in the news

Blogs on Cerebral venous sinus thrombosis differential diagnosis

Directions to Hospitals Treating Cerebral venous sinus thrombosis

Risk calculators and risk factors for Cerebral venous sinus thrombosis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sharmi Biswas, M.B.B.S

Overview

Cerebral venous sinus thrombosis is often get misdiagnosed due to the overlapping of symptoms with other neurological conditions

Differential Diagnosis

Cerebral venous sinus thrombosis should be differentiated from other diseases causing severe headache for example: [1][2][3][4][5][6][7][8][9][10]

Disease Symptoms Diagnosis
Gold Standard CT/MRI Other Investigation Findings
Intracranial venous thrombosis
  • Unable to move one or multiple limbs.
Digital subtraction angiography
Subarachnoid hemorrhage Digital subtraction angiography
Meningitis Lumbar puncture for CSF
Intracranial mass MRI
  • To detect intracranial lesions CT or MRI is the initial test of choice.
  • To determine the location of intracranial mass lesion(s) and treatment method, imgaing findings are helpful.
  • X- ray of the skull is a non specific test, but useful to identify calcified lesions.
Cerebral hemorrhage
  • Progressive focal neurological deficits
CT scan without contrast
  • CT scan without contrast is the initial test to differentiate ischemic stroke and rule out hemorrhagic stroke.
  • Acute hemorrhage appears as a hyperattenuating clot in CT scan.
  • Gradient echo and T2 susceptibility-weighted MRI are equally sensitive as CT for detection of acute hemorrhage and are more sensitive to identify prior hemorrhage.
Cerebral Infarction The symptoms of an ischemic stroke depend on the site and blood supply of the area involved. Cerebral angiography
Migraine --- Migraine does not need any diagnostic test; it is a clinical diagnosis. To rule out any suspected coexistent metabolic problems or to determine the baseline status of the patient before initiation of migraine therapy laboratory tests can be done.
Head injury CT scan without contrast
  • CT scan is the first test to identify cerebral hemorrhage (appears as hyperattenuating clot) after head injury.
  • MRI is time-consuming, expensive, and is done in cases with nonspecific findings in CT scans.
Lymphocytic hypophysitis Lymphocytic hypophysitis is most common in late pregnancy or the postpartum period with the following symptoms: Pituitary biopsy
Radiation injury Surgical exploration including biopsy (histological confirmation)

CT & MRI will show:

PET scan

References

  1. Endrit Ziu & Fassil Mesfin (2017). "Subarachnoid Hemorrhage". PMID 28722987.
  2. Benedikt Schwermer, Daniel Eschle & Constantine Bloch-Infanger (2017). "[Fever and Headache after a Vacation in Thailand]". Deutsche medizinische Wochenschrift (1946). 142 (14): 1063–1066. doi:10.1055/s-0043-106282. PMID 28728201.
  3. Otto Rapalino & Mark E. Mullins (2017). "Intracranial Infectious and Inflammatory Diseases Presenting as Neurosurgical Pathologies". Neurosurgery. doi:10.1093/neuros/nyx201. PMID 28575459.
  4. I. B. Komarova, V. P. Zykov, L. V. Ushakova, E. K. Nazarova, E. B. Novikova, O. V. Shuleshko & M. G. Samigulina (2017). "[Clinical and neuroimaging signs of cardioembolic stroke laboratory in children]". Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 117 (3. Vyp. 2): 11–19. doi:10.17116/jnevro20171173211-19. PMID 28665364.
  5. Sanjay Konakondla, Clemens M. Schirmer, Fengwu Li, Xiaogun Geng & Yuchuan Ding (2017). "New Developments in the Pathophysiology, Workup, and Diagnosis of Dural Venous Sinus Thrombosis (DVST) and a Systematic Review of Endovascular Treatments". Aging and disease. 8 (2): 136–148. doi:10.14336/AD.2016.0915. PMID 28400981.
  6. Priyanka Yadav, Alec L. Bradley & Jonathan H. Smith (2017). "Recognition of Chronic Migraine by Medicine Trainees: A Cross-Sectional Survey". Headache. doi:10.1111/head.13133. PMID 28653369.
  7. S. Wulffeld, L. S. Rasmussen, B. Hojlund Bech & J. Steinmetz (2017). "The effect of CT scanners in the trauma room - an observational study". Acta anaesthesiologica Scandinavica. 61 (7): 832–840. doi:10.1111/aas.12927. PMID 28635146.
  8. Johnston PC, Chew LS, Hamrahian AH, Kennedy L (2015). "Lymphocytic infundibulo-neurohypophysitis: a clinical overview". Endocrine. 50 (3): 531–6. doi:10.1007/s12020-015-0707-6. PMID 26219407.
  9. Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S (2017). "Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours". Nat Rev Neurol. 13 (1): 52–64. doi:10.1038/nrneurol.2016.185. PMID 27982041.
  10. Sato N, Sze G, Endo K (1998). "Hypophysitis: endocrinologic and dynamic MR findings". AJNR Am J Neuroradiol. 19 (3): 439–44. PMID 9541295.